These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 23317208)
1. Clinical and pathological factors related to the prognosis of chinese patients with stage Ib to IIb cervical cancer. Xie XZ; Song K; Cui B; Jiang J; Zhang YZ; Wang B; Yang XS; Kong BH Asian Pac J Cancer Prev; 2012; 13(11):5505-10. PubMed ID: 23317208 [TBL] [Abstract][Full Text] [Related]
2. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy. Takeda N; Sakuragi N; Takeda M; Okamoto K; Kuwabara M; Negishi H; Oikawa M; Yamamoto R; Yamada H; Fujimoto S Acta Obstet Gynecol Scand; 2002 Dec; 81(12):1144-51. PubMed ID: 12519111 [TBL] [Abstract][Full Text] [Related]
3. Risk factors and prognosis of IB-IIB cervical carcinoma with common iliac lymph node metastasis. Huang L; Zheng M; Liu JH; Xiong Y; Ding H; Tang L; Wang HY Chin J Cancer; 2010 Apr; 29(4):431-5. PubMed ID: 20346221 [TBL] [Abstract][Full Text] [Related]
4. Predictors for pathological parametrial invasion in clinical stage IIB cervical cancer. Matsuo K; Shimada M; Nakamura K; Takei Y; Ushijima K; Sumi T; Ohara T; Yahata H; Mikami M; Sugiyama T Eur J Surg Oncol; 2019 Aug; 45(8):1417-1424. PubMed ID: 30846298 [TBL] [Abstract][Full Text] [Related]
5. [Analysis of prognostic factors in patients with cervical squamous cell carcinoma of stage Ib and IIa]. Chen L; Lü WG; Xie X; Chen HZ; Yu H; Ni XH Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):239-42. PubMed ID: 15924669 [TBL] [Abstract][Full Text] [Related]
6. A comparison of the prognosis between adenocarcinoma and squamous cell carcinoma in stage IB-IIA cervical cancer. Xie X; Song K; Cui B; Jiang J; Yang X; Kong B Int J Clin Oncol; 2018 Jun; 23(3):522-531. PubMed ID: 29299705 [TBL] [Abstract][Full Text] [Related]
7. Histopathological factors influencing pelvic lymph node metastases in two or more sites in patients with cervical carcinoma undergoing radical hysterectomy. Kamura T; Shigematsu T; Kaku T; Shimamoto T; Saito T; Sakai K; Mitsumoto M; Nakano H Acta Obstet Gynecol Scand; 1999 May; 78(5):452-7. PubMed ID: 10326894 [TBL] [Abstract][Full Text] [Related]
8. Lymphovascular and perineural invasion in the parametria: a prognostic factor for early-stage cervical cancer. Memarzadeh S; Natarajan S; Dandade DP; Ostrzega N; Saber PA; Busuttil A; Lentz SE; Berek JS Obstet Gynecol; 2003 Sep; 102(3):612-9. PubMed ID: 12962952 [TBL] [Abstract][Full Text] [Related]
9. Can pelvic lymphadenectomy be omitted in stage IA2 to IIB uterine cervical cancer? Togami S; Kamio M; Yanazume S; Yoshinaga M; Douchi T Int J Gynecol Cancer; 2014 Jul; 24(6):1072-6. PubMed ID: 24905616 [TBL] [Abstract][Full Text] [Related]
10. [The rule of metastatic pelvic lymph node distribution in patients with early stage cervical carcinoma]. Zhang HY; Sheng XG; Zhong Y; Ma ZF; Ma YB; Liu NF; Chen YT; Wang YY Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):452-5. PubMed ID: 19024522 [TBL] [Abstract][Full Text] [Related]
11. Twelve years experience with radical hysterectomy and pelvic lymphadenectomy in early stage cervical cancer. Suprasert P; Srisomboon J; Charoenkwan K; Siriaree S; Cheewakriangkrai C; Kietpeerakool C; Phongnarisorn C; Sae-Teng J J Obstet Gynaecol; 2010 Apr; 30(3):294-8. PubMed ID: 20373935 [TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume. Trattner M; Graf AH; Lax S; Forstner R; Dandachi N; Haas J; Pickel H; Reich O; Staudach A; Winter R Gynecol Oncol; 2001 Jul; 82(1):11-6. PubMed ID: 11426955 [TBL] [Abstract][Full Text] [Related]
13. Radical hysterectomy with or without para-aortic lymphadenectomy for patients with stage IB2, IIA2, and IIB cervical cancer: outcomes for a series of 308 patients. Tsuruga T; Fujimoto A; Kawana K; Mori M; Hasumi Y; Kino N; Tomio K; Miura S; Tanikawa M; Sone K; Miyamoto Y; Ikeda Y; Kojima S; Adachi K; Nagasaka K; Matsumoto Y; Arimoto T; Oda K; Nakagawa S; Horie K; Yasugi T; Yokota H; Osuga Y; Fujii T Int J Clin Oncol; 2016 Apr; 21(2):359-366. PubMed ID: 26438230 [TBL] [Abstract][Full Text] [Related]
14. Lymphadenectomy alone is a feasible option in managing incidentally-detected early-stage cervical cancer after simple hysterectomy without intermediate-risk factors: An application of the concept of less radical surgery. Jeon HW; Suh DH; Kim K; No JH; Kim YB Anticancer Res; 2013 Nov; 33(11):5135-41. PubMed ID: 24222161 [TBL] [Abstract][Full Text] [Related]
16. [Results of different postoperative adjuvant therapies for stage Ib-IIa cervical carcinoma with risk factors]. Wen HW; Huang WP; Liu TY; Ma K; Tao X; Zhu LR; Liao QP Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):920-4. PubMed ID: 24495686 [TBL] [Abstract][Full Text] [Related]
17. Prognosis and clinicopathological characteristics of Ib-IIb adenocarcinoma of the uterine cervix in patients who have had radical hysterectomy. Irie T; Kigawa J; Minagawa Y; Itamochi H; Sato S; Akeshima R; Terakawa N Eur J Surg Oncol; 2000 Aug; 26(5):464-7. PubMed ID: 11016467 [TBL] [Abstract][Full Text] [Related]
18. The Number of Positive Pelvic Lymph Nodes and Multiple Groups of Pelvic Lymph Node Metastasis Influence Prognosis in Stage IA-IIB Cervical Squamous Cell Carcinoma. Liu Y; Zhao LJ; Li MZ; Li MX; Wang JL; Wei LH Chin Med J (Engl); 2015 Aug; 128(15):2084-9. PubMed ID: 26228223 [TBL] [Abstract][Full Text] [Related]
19. Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with Stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy. Sakuragi N; Satoh C; Takeda N; Hareyama H; Takeda M; Yamamoto R; Fujimoto T; Oikawa M; Fujino T; Fujimoto S Cancer; 1999 Apr; 85(7):1547-54. PubMed ID: 10193945 [TBL] [Abstract][Full Text] [Related]
20. An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study. Look KY; Brunetto VL; Clarke-Pearson DL; Averette HE; Major FJ; Alvarez RD; Homesley HD; Zaino RJ Gynecol Oncol; 1996 Dec; 63(3):304-11. PubMed ID: 8946863 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]